Molina's amended purchase price spells trouble for Bright Health

The latest stories trending on MedCity News.

Editor's Pick

Top Story 'We're Getting Closer and Closer To Bright Going Dark': Molina Lowers Purchase Price for Bright Health Group's MA Business Molina Healthcare's purchase price of Bright Health Group's Medicare Advantage business has dropped from $600 million to $500 million. This will make it increasingly difficult for Bright Health to pay off its debts, one expert said. Sponsored Content Elevating Patient Experience Through Informed Decision-Making Presented by MedCity News & Care Logistics While many healthcare leaders are familiar with situational awareness, there's a crucial step beyond—an evolution towards "informed awareness". Unlike its predecessor, informed awareness transcends traditional boundaries, weaving past, present, and future insights into the fabric of decision-making. Dr. Christopher Newman, Executive Vice President, Chief Operating Officer, and Chief Medical Officer of Mary Washington Healthcare, delves into the power of informed decision-making, exploring its profound impact on the patient experience and operational efficiency. Read the full article here Apply to INVEST 2024 Pitch Contest Now Pitch your startup at INVEST 2024 for a chance to win a $20,000 advertising credit on MedCityNews.com. Select one track from four options (Biopharma, Devices & Diagnostics, Healthtech: Consumer/Employer, Healthtech: Payer/Provider). Each track will feature six finalists. Deadline to apply is February 29, 2024. Finalists will be announced starting March 31, 2024. There is no fee to apply. Apply Now!

Featured News

Chiesi Rare Skin Disease Drug Acquired in Billion Dollar Deal Wins FDA Approval Chiesi Group's Filsuvez is the second drug to win FDA approval for epidermolysis bullosa and the first for junctional EB, a more severe form of the rare skin disease. The birch tree bark-derived drug is from Chiesi's $1.25 billion Amryt Pharma acquisition. Study: Virtual Doula Care Improves Maternal Health Outcomes A recent peer-reviewed study from Maven Clinic found that virtual doulas significantly reduced the chances of a C-section, especially among Black mothers. Butterfly Network Partners with Mendaera to Co-Develop a 'New Category of Robotics' Butterfly Network announced a product co-development deal with surgical robotics startup Mendaera, in which the startup will build custom robotics around Butterfly's ultrasound-on-a-chip technology to create a new system designed for better surgical precision and consistency. Both partners expect to complete the product's FDA submission by 2025. AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time Despite artificial intelligence's growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it's too early to focus on winning a race that has many twists and turns yet to come. Gene Therapy and a New Medicine Delivery Approach Signal Progress for Cystic Fibrosis Patients It's time to build the infrastructure needed to scale up inhaled gene therapies targeting cystic fibrosis, and to bolster investment that supports several key program components.

Resources

How a Health Center Serving Low Income Patients Engaged Them In Their Own Health In the last episode of the year, Wrobel, CEO of an Indiana-based federally qualified health center, describes how a survey helped her and her community workers understand exactly how confident her patients are in managing their own care and the best way to help them with the ultimate goal of improving overall health equity. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe